Effects of Gastrostomy on Amyotrophic Lateral Sclerosis
NCT ID: NCT00337402
Last Updated: 2006-11-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
380 participants
OBSERVATIONAL
2002-01-31
2005-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
DEFINED_POPULATION
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ALS certain or probable
* vital capacity (respiratory) \> 70 %
* under riluzole
Exclusion Criteria
* other conditions affected survival and QoL
* cognitive impairment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Angers
OTHER_GOV
University Hospital, Bordeaux
OTHER
University Hospital, Caen
OTHER
University Hospital, Grenoble
OTHER
University Hospital, Lille
OTHER
University Hospital, Limoges
OTHER
Neurological department of Lyon University Hospital
UNKNOWN
University Hospital, Marseille
OTHER
University Hospital, Montpellier
OTHER
Central Hospital, Nancy, France
OTHER
Centre Hospitalier Universitaire de Nice
OTHER
University Hospital, Paris
OTHER
University Hospital, Strasbourg
OTHER
University Hospital, Toulouse
OTHER
University Hospital, Tours
OTHER
University Hospital, Clermont-Ferrand
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre Clavelou
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clermont-Ferrand University Hospital
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHU63-0001
Identifier Type: -
Identifier Source: org_study_id